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ABSTRACT 
Introduction: Cancer is caused by abnormalities in genetic material of the transformed cells. Cancer may also be initiated by carcinogens, 
tobacco, smoke, radiation, chemicals or infectious agents, especially some viruses. Cancers cause annually more than 13% of all human deaths. 
More than 70% of all cancer deaths occurred in low and middle income countries. Deaths from cancer worldwide are projected to  continue 
rising, with an estimated 12 million deaths in 2030 (WHO estimate). Natural products have been used as traditional medicines in many parts of 
the world like Egypt, China, Greece, and India from ancient times. It is from these medicinal plants, the modern drugs been d eveloped known to 
be free of the deleterious effects, are inexpensive and effective. One of these herbs is Wheatgrass, the young grass of Triticum aestivum Linn., 
family: Poeaceae. Objectives: Objective of the study was to analyze anticancer property of leaves of Triticum aestivum on HCT-15 cells. 
Materials and methods: The young grass of Triticum aestivum is was collected. The aqueous extract was prepared by using standard protocols. 
The antiproliferative effect of the aqueous extract was evaluated in vitro by employing MTT assay. The potency of plant extract was calculated 
in terms of percent decrease in viable HCT-15 cells as compared to the control. Result and conclusion: The extract showed dose dependent 
antitumor activity. The MTT assay showed an anti proliferative activity (IC50) at 258.8 μg/ml of crude extract. 
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INTRODUCTION 
Cancer is one of the major human diseases and causes large 
suffering and economic loss worldwide. Colorectal 
carcinoma is the third most commonly diagnosed cancer 
worldwide with a prevalence of 1.4 million (9.7%) preceded 
by lung cancer (13.0%) and breast cancer (11.9%), despite 
all the advanced therapeutic and surgical interventions 
available.[1,2]  Given the temporal profiles and demographic 
projections, the global burden of CRC is expected to increase 
by 60% to more than 2.2 million new cases and 1.1 million 
cancer deaths by 2030.[3] Hence, it is the need of the hour to 
plunge our fingers into the field of research to find out safer 
and more effective therapeutic modalities which not only 
would limit the spread of colorectal carcinoma but also 
would ensure patient's wellbeing by having minimal adverse 
effects unlike the current day chemotherapeutic regimens. 
Various new strategies are being developed to control and 
treat several human cancers[4]. Over 60% of anticancer 
drugs available in the market are of natural origin. Natural 
products are also the lead molecules for many of the drugs 
that are in use. [5] Therefore, the phytochemicals present in 
several herbal products and plants may have the potential to 
act as preventive or therapeutic agents against various 
human cancers. [4] The increased popularity of herbal 
remedies for cancer therapy perhaps can be attributed to the 
belief that herbal drugs provide benefit over that of 
allopathy medicines while being less toxic. [6] Since the 
conventional therapies have devastating side effects, there is 
a continuous need for search of new herbal cures of cancer. 
[7]  
Triticum aestivum 
Wheat, (Triticum species) a cereal grass of the Gramineae 
(Poaceae) family, is the world's largest edible grain cereal-
grass crop. It is commonly 60-150 cm. in height, but may be 
as short as 30 cm. Stem is tufted, erect or semi-erect to 
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prostrate, generally hollow with thin walls, in stem nodes 
are present generally 5-7 at 3-4 cm. Leaves are long and 
narrow having glabrous or hairy on one or both surface.[8,9] 
Scientific reports on nutritional analysis of wheatgrass have 
been published frequently in various 
Journals. [10,11,12] These reports and the chemical analyses 
undertaken reveal that wheatgrass is rich in chlorophyll, 
minerals and trace elements including calcium, iodine, 
magnesium, selenium, zinc, chromium, antioxidants like beta 
carotene (pro-vitamin A), vitamin B1, vitamin E, vitamin C, 
anti-anemic factors like vitamin B12, iron, folic acid, 
pyridoxine and many other minerals, amino acids and 
enzymes, which have significant nutritious and medicinal 
value. [8] 
Wheatgrass is known to contain antioxidant enzymes 
superoxide dismutase (SOD) and cytochrome oxidase that 
have the potential to convert reactive oxygen species (ROS) 
to a hydrogen peroxide and an oxygen molecule. [13] 
Chlorophyll, one of the primary components in the 
wheatgrass, was found to augment blood formation and 
strengthen the immune system through inhibition of 
metabolic activation of carcinogens. [14, 15] It also possesses 
the ability to inhibit oxidative DNA damage. [16]  
Dr. Ann Wigmore, founder director of the Hippocrates 
Health Institute, Boston, U.S.A., she claimed that wheatgrass 
is a safe and effective treatment for ailments such as high 
blood pressure, some cancers, obesity, diabetes, gastritis, 
ulcers, anemia, asthma and eczema. [17] Few clinical trials 
have been accomplished that have shown on consumption of 
wheatgrass juice, the number of transfusions in patients 
with thalassemia major is decreased. [18] Reduction in the 
overall disease activity index and the severity of rectal 
bleeding in cases of distal ulcerative colitis on consumption 
of wheatgrass juice has also been observed. [19] 
VERO Cell line 
The Vero lineage was isolated from kidney epithelial cells 
extracted from an African green monkey. The lineage was 
developed on 27 March 1962, by Yasumura and Kawakita at 
the Chiba University in Chiba, Japan. [20] The original cell line 
was named "Vero" after an abbreviation of "Verda Reno", 
which means "green kidney" in esperanto, while "Vero" itself 
means "truth" also in Esperanto. [21] Vero cells are one of the 
most common mammalian continuous cell lines used in 
research. [22]  
HCT-15 Cell Line: 
HCT-15 is a human colorectal adeno-carcinoma that has a 
mutated p53 tumor suppressor gene and over expresses P-
glycoprotein. P-glycoprotein acts as an efflux pump resulting 
in decreased intracellular accumulation of certain drugs 
contributing to drug resistance. 
MATERIALS AND METHODS 
Plant Material 
Certified sample of Triticum aestivum (Wheatgrass), was 
acquired from Anand Agricultural University, Gujarat. The 
authenticity of this certified sample was also confirmed by 
comparing its morphological characters with the description 
mentioned in different standard texts and floras.[23] Voucher 
specimen of the plant has been deposited at Department of 
Pharmacognosy, B. Pharmacy College, Rampura, Kakanpura, 
Godhra, Dist. Panchmahal, Gujarat, India for future 
reference. This wheat variety was grown in plastic tray as 
per the standard procedure described below. [17] 
Procedure for growing wheatgrass 
 Adequate quantities of unpolished wheat grain were 
soaked overnight in water in a container. 
 On the next day, the soaked wheat-grain were spread 
on the surface of the soil filled in plastic trays. Care was 
taken so that the grains did not touch one another. 
 A thin layer of soil was sprinkled on the wheat grains 
and then tray was covered with a newspaper to 
provide darkness, which helps the sprouting. 
 The tray was kept in a covered balcony. Next day the 
tray was uncovered to spray on some water and was 
covered again with the newspaper. 
 Previous step was repeated every day until sprouting 
took place, after which the tray was left uncovered and 
watered everyday for 8 days. 
 On 9th day the wheatgrass was harvested by cutting it 
with a clean pair of scissors about 1/2" above the 
surface of the soil. 
Preparation of aqueous extract: 
For preparation of aqueous extract, 100 g of fresh 
wheatgrass was crushed thoroughly, using mortar and 
pestle. The crushed wheatgrass was completely exhausted 
by adding small quantities of water several times followed 
by filtration, to yield final volume of 1 liter. The extract was 
filtered and concentrated to dryness under reduced 
pressure and controlled temperature (40 ºC to 50 ºC) in a 
rotary evaporator.  The dried extract was dissolved in 
Dimethyl sulphoxide (DMSO) to prepare the stock solution 
100 mg/ml. 
Determination of cell viability by trypan blue dye 
exclusion method: 
The viability of cells was determined by the Trypan Blue dye 
exclusion method. It takes advantage of the ability of healthy 
cells with uncompromised cytoplasmic membrane integrity 
to exclude dyes such as trypan blue. [24] 
1. Hemocytometer cell counts: 
 Hemocytometer & cover slip were cleaned and wipe 
with 70% alcohol. Cover slip was placed on 
hemocytometer. In the separate 2ml centrifuge tube, 
cell suspension (cells in culture media) was added. 
Two fold dilution of reaction mixture was prepared by 
mixing aliquot of 0.1 ml cell suspensions with 0.1 ml 
trypan blue. 
 Afterwards 0.1ml of Cell suspension was placed in to 
the chamber of hemocytometer. 
 By using a Lieca inverted microscope, numbers of cells 
were counted in 1mm2 area under 10X objective. 
 Viable & non-viable cells were counted in both halves 
of the chamber. 
2. Calculations: 
1) Total number of viable cells = A XBX C X 104 
2) Total dead cell count = A X B X D X 104 
  Where, 
  A = Vol. Of cell solution (ml) 
  B = Dilution factor in trypan blue 
  C = Mean number of unstained cells 
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  D = Mean number of dead/stained cells 
  104 = Conversion of 0.1 mm3 to ml 
3)  Total cell count = Viable cell count + dead cell count 
% viability = (Viable cell count/Total cell count) X 100 
(Vol.: Volume, CS: Cell Solution TB: Trypan blue) 
In-vitro evaluation of anticancer activity by MTT assay  
Cell culture  
The human colon cancer cell line (HCT- 15) & Vero (normal 
kidney cells) was provided by National Centre for Cell 
Science (NCCS), Pune. Stock cells of these cell lines were 
cultured in DMEM (high glucose) or Eagle’s Minimum 
Essential Medium (EMEM) with 10% fetal bovine serum 
(FBS). All cells were maintained at 37°C, 5% CO2, 95% air. 
Cells were used in experiments during the linear phase of 
growth. 
Preparation of working herbal extracts 
0.5ml of stock (100 mg/ml) herbal extract was dissolved in 
4.5 ml of DMSO giving a concentration of 10mg/ml. 10 µl of 
10 mg conc. of test compound was added in to 900 µl of 
complete media and as a result 100 µg conc. of test sample 
was obtained. Than 1:3 dilution of test sample was done as 
shown in Table 1. It was done by mixing 50 µl of test 
compound with 100 µl of complete media. For this, initially 
100 µl of complete media was added in to well no. 1 – 9. Well 
10 contained 150 µl test substance only, from that 50 µl was 
pipetted out and added into well no. 9 which already contain 
100 µl of complete media, which lead to 1:3 dilution of test 
sample. Same procedure was repeated 9 times in order to 
get final conc. of test Sample up to 0.005 µm. (Table 1). 
Colchicine was used as a reference standard for the 
comparison of activity of the extract and dilutions were 
prepared as that of sample extract. 
 
Table 1: (1:3) dilution of test compound used in the assay 
well no:1-9 contain  complete media 100  µl + Test Compound 30  µl 
Well no: 1 2 3 4 5 6 7 8 9 10 
Compound dilution 
50 µl 
T.C  
from 
well   2 
50 µl 
T.C 
from 
well 3 
50 µl 
T.C 
from 
well    4 
50 µl 
T.C 
from 
well 5 
50µl 
T.C 
from 
well6 
50µl 
T.C 
from 
well 7 
50µl 
T.C 
from 
well 8 
50µl T.C 
from 
well  
9 
50µl 
T.C 
from 
well 10 
150µl 
T.C 
Final conc.  (µm) 
0.05 
µg  
0.15  
µg 
0.46  µg 
1.37  
µg 
4.12  
µg 
12.35 
µg 
37.04  
µg 
111.1  
 µg 
333.3  
µg 
1000 
µg 
Where, T.C= Test Compound; C.M= Culture Media 
Cytotoxicity assay 
Principle 
This Colorimetric assay is based on the capacity of 
Mitochondria succinate dehydrogenase enzymes in living 
cells to reduce the yellow water soluble substrate 3- (4, 5-
dimethyl thiazol-2-yl)-2, 5-diphenyl tetrazolium bromide 
(MTT) into an insoluble, purple colored formazan product 
which is measured spectrophotometrically. [25-27] This 
formazan production is directly proportional to the viable 
cell number and inversely proportional to the degree of 
cytotoxicity. [28-29] 
MTT assay [23,27,30‐32] 
Protocol: 
 Cells were preincubated at a concentration of 1 × 1 06 
cells / ml in culture medium for 3 hrs at 37°C and 6.5 % 
CO2, 75 % Relative Humidity.  
 Cells were seeded at a concentration of 5 × 10 4 cells / 
well in 100 µl culture medium and various amount of 
compound and standard (final concentration, e.g. 1000 
µg/ml – 0.05µg/ml) were added into microplates 
(tissue culture grade, 96 wells, flat bottom).  
 Cell cultures were incubated for 24 hrs at 37 °C and 
6.5% CO2.  
 10 µl MTT labeling mixture was added and incubate for 
4 hrs at 37 °C and 6.5 % CO2, 75 % Relative Humidity.  
 100 µl of solubilization solution was added to each well 
and incubate for overnight.  
 Absorbance of the samples was measured using a 
microplate (ELISA) reader. The wavelength to measure 
absorbance of the formazan product is between 540 
and 600 nm according to the filters available for the 
ELISA reader, used. (The reference wavelength should 
be more than 650 nm).  
Data interpretation: 
Absorbance values that are lower than the control cells 
indicate a reduction in the rate of cell proliferation. 
Conversely a higher absorbance rate indicates an increase in 
cell proliferation. Rarely, an increase in proliferation may be 
offset by cell death; evidence of cell death may be inferred 
from morphological changes. 
After 24 hrs, the cytotoxicity data were evaluated by 
determining absorbance and calculating the correspondent 
chemical concentrations. Linear regression analysis with 95 
% confidence limit and R2 were used to define dose-response 
curves and to compute the concentration of chemical agents 
needed to reduce absorbance of the formazan by 50 % (IC50). 
Percentage cell growth inhibition or percentage cytotoxicity 
was calculated by following formula: 
% viability = (AT – AB) / (AC – AB) × 100……… (1) 
Where, 
AT = Absorbance of treated cells (drug) 
AB = Absorbance of blank (only media) 
AC = Absorbance of control (untreated) 
There by, 
% cytotoxicity = 100 –  % cell survival … … … (2)  
% Cell viability % = Mean OD of wells receiving each plant 
extract dilution/ Mean OD of control wells x 100… …. …(3) 
Cell death % = 1 – (OD of sample/OD of control) x 100… …(4) 
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Determination of IC50 value:  
According to FDA, IC50 represents the concentration of a drug 
that is required for 50 % inhibition in-vitro. In the present 
study, IC50 is a concentration of drug at which 50 % of cell 
population die. 
For primary screening, a threshold of 50 % cell growth 
inhibition as a cut off for compound toxicity against cell lines. 
IC50 determined from plot of Dose Response curve between 
log of compound concentration and percentage growth 
inhibition.  
Graph was plotted by keeping log concentration of drug on X 
axis and % cell growth inhibition or % cytotoxicity Y axis. 
IC50 was estimated as a concentration of the drug at 50 % 
position on the Y axis. 
RESULTS AND DISCUSSION 
In order to evaluate the cytotoxic effect of aqueous extract of 
Triticum aestivum, a MTT assay with HCT-15 (human 
colorectal adenocarcinoma) & Vero (normal kidney cells) cell 
line was performed. The extract was screened for its 
cytotoxicity at different concentrations to determine the IC50 
(50% growth inhibition) value. The cytotoxic effect of extract 
was compared with colchicine as the reference standard. 
A chart was plotted using the % cell inhibition in Y‐axis and 
concentration of the plant extract in X‐axis. The results are 
tabulated in (Table 2) and graphically represented (Fig. 1).
 
Table 2: % Cell inhibition on VERO & HCT-15 cell lines by aqueous extract of leaves of Triticum aestivum. 
Sr. no Conc. µg/ml Log conc VERO HCT-15 
1 0.05 -1.29 -93.85 -23.85 
2 0.15 -0.82 -116.4 -32.35 
3 0.46 -0.34 -115 -23.03 
4 1.37 0.14 -115.6 -34.67 
5 4.12 0.61 -115.4 -28.4 
6 12.35 1.09 -114 -22.46 
7 37.04 1.57 -91.66 -12.81 
8 111.11 2.05 -60.82 9.27 
9 333.33 2.52 1.28 30.12 
10 1000 3 37.49 63.14 
 
 
Fig. 1: Dose response curve of aqueous extract of leaves of Triticum aestivum on HCT-15 and VERO-cell-lines. 
 
When HCT-15 and VERO cells were treated with the aqueous 
extract of the leaves of Triticum aestivum and colchicine, 
there was a concentration dependent cytotoxic effect. As the 
concentration increased from 0.05 – 1,000 μg/ml, percentage 
of inhibition increases from            -93.85% to 37.49 for VERO 
cell line and -23.85 % to 63.14 % for HCT-15 cell line.   The 
IC50 value was found to be 1000 μg/ml for VERO cell line 
and 258.8 μg/ml for HCT-15 cell line from the graph and R2 
values 0.9783 for VERO cell line and 0.9832 for HCT-15 cell 
line (Table 3).  
Colchicine was used as a reference standard for the 
comparison of activity of aqueous extract. Colchicine was 
evaluated in the same cellular system VERO & HCT-15 to 
obtain cytotoxicity parameters. As the concentration 
increased from 0.05 – 1,000 μg/ml, percentage of inhibition 
increases from 0.85 % to 37.49% for VERO cell line and 4.37 
% to 67.99 % for HCT-15 cell line (Table 4) and graphically 
represented (Fig 2). 
Table 3:  IC50 and R2 values of aqueous extract of leaves 
of Triticum aestivum. 
Parameters VERO HCT-15 
IC50 Value 1000 258.8 
R2 0.9783 0.9832 
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Table 4: % Cell inhibition on VERO & HCT-15 cell lines by colchicine. 
Sr. no Conc. µg/ml  Log conc VERO HCT-15 
1 0.05 -1.29 0.85 4.37 
2 0.15 -0.82 0.35 7.34 
3 0.46 -0.34 1.02 7.98 
4 1.37 0.14 1.63 9.04 
5 4.12 0.61 2.44 13.31 
6 12.35 1.09 14.97 19.7 
7 37.04 1.57 19.66 23.88 
8 111.11 2.05 20.82 38.95 
9 333.33 2.52 29.28 41.88 
10 1000 3 37.49 67.99 
 
 
 
Fig. 2: Dose response curve of colchicine on HCT-15 and 
VERO-cell-lines. 
The IC50 value was found to be 1000 μg/ml for VERO cell 
line and 139.1 μg/ml for HCT-15 cell line from the graph and 
R2 values 0.9471 for VERO cell line and 0.9444 for HCT-15 
cell line (Table 5). 
Table 5:  IC50 and R2 values of Colchicine.  
Parameters VERO HCT-15 
IC50 Value 1000 139.1 
R2 0.9471 0.9444 
 
Traditionally many medicinal plants, which possess the 
ability to prevent and even to stall the progress of cancer, 
were in use. Plants possess certain chemicals, which have the 
ability to modify the physiological function of cells and hence 
act as anti‐cancer drugs to arrest the proliferation of cancer 
cells. The mode of action of the drugs is unknown but 
successfully integrating our documented knowledge of plant 
properties and modern technological tools, effective 
anti‐cancer drugs can be derived from plant sources and 
their mechanism can be elucidated.[33-35] 
The present need is to develop drugs that can potentially 
target cancer cells by means of their inherent difference to 
normal cells. The development of such drugs with 
differential action will be very valuable in cancer 
chemotherapy without the observed side effects. The 
methodology involves use of cancer cell lines to test the 
efficacy of the plant extracts in vitro. 
The potential use of Triticum aestivum as therapeutic agent 
holds great promise as the isolation of one or more cytotoxic 
chemicals from crude extract and the judicious use of such 
chemicals can control the progression of cancer and also can 
prevent the formation of tumour in individuals who are 
highly susceptible to developing a tumour. 
CONCLUSION  
The results obtained from the in-vitro studies performed 
using the HCT-15 cell lines reveals that the aqueous extract 
of Triticum aestivum has a moderate anticancer activity. The 
extract did not show any cytotoxic potential to the normal 
cell line i.e. Vero cell line. Even though there was increase in 
the cell growth inhibition when concentration of sample was 
increased, the IC50 value was 258.8 μg/ml for the HCT-15 
cell line as shown by the MTT assay method. This holds great 
promise for future research in human beings. The anticancer 
property of Triticum aestivum will provide useful 
information in the possible application in the prevention and 
treatment of cancer.   
ACKNOWLEDGEMENT  
I am heartly thankful to Dr. S. S. Pandya, Principal, Trustees & 
management of B. Pharmacy College, Rampura– Kakanpur 
for providing infrastructural facilities for this work, kind 
support and guidance in the work. I would like to record my 
gratitude to prof. P.M.Patel, Examination controller , Gujarat 
University, Ahmedabad and Dr. Vipul Patel for his consent, 
motivation and suggestions. I am thankful to my parents, my 
brother, bhabhi, my little angel Swara, my little boy Aarav, 
Dr. Sagar Patel and all my colleagues. They inspired me, 
encouraged me in a variety of ways, their love, care, patience, 
guidance and support for influencing me and giving immense 
support to me. 
REFERENCES 
1. WHO; IARC (International Agency for Research on Cancer); 
Latest World Cancer Statistics, Global Cancer Burden Rises to 
14.1 Million New Cases in 2012, 12th December 2013 Press 
Release No. 233. [Last accessed on 2015 Jun 17]. Available 
from: 
http://www.iarc.fr/en/mediacentre/pr/2013/pdfs/pr223_E.
pdf . 
2. GLOBOCAN 2012 Estimated Cancer Incidence, Mortality and 
Prevalence About Colorectal Carcinoma, Worldwide in 2012. 
[Last accessed on 2015 Jun 19]. Available from: 
http://www.globocan.iarc.fr/pages/fact_sheets_cancer.aspx?c
ancer=colorectal . 
3. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 
v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer 
Base No. 11. Lyon, France: International Agency for Research 
on Cancer, 2013. 
0
20
40
60
80
100
120
HCT-15
VERO
Patel et al                                                                                                                  Journal of Drug Delivery & Therapeutics. 2019; 9(4):164-169 
 
ISSN: 2250-1177                                                                                  [169]                                                                                 CODEN (USA): JDDTAO 
4. Modha J, Modha N. International Centre for Ayurveda Studies. 
Jamnagar, Gujarat, India: Gujarat Ayurveda University; 2007. 
Role of Ayurveda in the Management of Cancer. 
5. Cragg GM, Newman DJ, Snader KM. Natural products in drug 
discovery and development. Journal of  Natural Products, 
1997;60:52–60. [PubMed: 9014353]. 
6. Gupta S, Zhang D, Yi J, Shao J. Anticancer activities of 
Oldelandia diffusa. Journal of Herbal Pharmacotherapy, 
2004;4:21–33. [PubMed: 15273074]. 
7. Aquil F, Ahmad I, Mehmood Z. Antioxidant and free radical 
scavenging properties of twelve traditionally used Indian 
medicinal plants. Trukish Journal of Biology, 2006;30:177–83. 
8. The wealth of India, Council of Scientific & Industrial research, 
New Delhi, 10, 312-323. 
9. Schnabel C, The biologic value of high protein cereal grasses. 
Paper presented to the biologic section of the American 
Chemical Society, New York, April 2, 1940. 
10. Laboratory Analyses, Nutrition International, East Brunswick, 
NJ, Sep 6, 1989. 
11. Hamilton E, Whitney E, Sizer F, Nutrition: Concepts and 
Controversies. West Publishing Co., St. Paul, Minn, 4th ed, 
1988. 
12. Kohler G, The unidentified vitamins of grass and alfalfa, 
Feedstuffs, Aug. 8, 1953. 
13. Padalia S et al., Multitude potential of wheatgrass juice (Green 
Blood) An Overview, Chronicles of young scientists 2011;1: 
23-24. 
14. Lai CN, Chlorophyll: the active factor in wheat sprout extracts 
inhibiting the metabolic activation of carcinogens in vitro, 
Nutrition and Cancer, 1979; 1: 19–21. 
15. Lai CN, Dabney BJ, Shaw CR, Inhibition of in vitro metabolic 
activation of carcinogens by wheat sprout extracts. Nutrition 
and Cancer 1978; 1: 27–30. 
16. Falcioni G, Fedeli D, Tiano I, Antioxidant activity of wheat 
sprout extracts in vitro: Inhibition of DNA oxidative damage, 
Journal of Food Science, 2002; 67: 2918-2922. 
17. Wigmore A, The wheatgrass Book, Avery Publishing Group, 
Wayne, New Jersey, 1985. 
18. Marwaha R et al., Wheat Grass Juice Reduces Transfusion 
Requirement in Patients with Thalassemia Major: A Pilot 
Study, Indian Pediatrics, 2004, 41. 
19. Ben-Arye E et al., Wheatgrass juice in the treatment of active 
distal ulcerative colitis: a random double-blind placebo-
controlled trial, Scand Journal of Gastroenterology, 2002; 37: 
444–449. 
20. Yasumura Y, Kawakita M, The research for the SV40 by means 
of tissue culture technique, Nippon Rinsho, 1963; 21(6): 
1201–1219. 
21. Shimizu B, In Seno K, Koyama H, Kuroki T, Manual of selected 
cultured cell lines for bioscience and biotechnology (in 
Japanese), Tokyo, Kyoritsu Shuppan, 1993, 299–300. 
22. Ammerman NC, Magda Beier-Sexton, Abdu FA, Growth and 
Maintenance of Vero Cell Lines, Current Protocol 
Microbiology, 2008: 1-10. 
23. Percival J, In: The wheat plant, Duckworth, U K, 1974, 55-59. 
24. Freshney RI, Animal cell culture- a practical approach,2002.  
25. Mosmann T, Rapid Colorimetric Assay for Cellular Growth and 
Survival: Application to Proliferation and Cytotoxicity Assays, 
Journal of Immunology Methods, 1983; 65: 55-63. 
26. Wilson AP, Cytotoxicity and Viability Assays in Animal Cell 
Culture: A Practical Approach, 3rd Ed, Oxford University Press, 
Oxford, 2000, 1. 
27. Patel S, Gheewala N, Suthar A, Shah A, In- vitro cytotoxicity 
activity of Solanum Nigrum extract against Hela cell line. 
International journal of pharmacy and pharmaceutical 
sciences, 2009; 1(1): 38-46. 
28. Berridge MV, Herst PM, Tan AS, Tetrazolium dyes as tools in 
cell biology: New insights into their cellular reduction. In: El-
Gewely MR, editor, Biotechnology Annual Review. Amsterdam, 
Elsevier; 2005, 127–152. 
29. Mantani N, Imanishi N, Kawamata, H, Terasawa K, Ochiai H, 
Inhibitory effect of (+)-catechin on the growth of influenza 
A/PR/8 virus in MDCK cells. Planta Medica, 2001; 67: 240‐43. 
30. Jack D Burton, The MTT assay to evaluate chemosensitivity. 
Chemosensitivity,  Humana Press Inc. Totowa, NJ, 2005m 1: 
69‐77. 
31. Quintero A, Pelcastre A, Solano JD, Cytotoxic activity of crude 
extracts from  Astragalus chrysochlorus (Leguminosae). 
Journal of Pharmacy and Pharmaceutical Science, 1999; 2: 
108-112. 
32. Taylor RSL, Manendhar NP, Hudson JB, Towers GHN, Antiviral 
activities of Nepalese medicinal plants, Journal of 
Ethnopharmacology, 1996; 52: 157‐63. 
33. Vlietink AJ, Van Hoof L, Totte J, Lasure A, Vanden Berghe D, 
Rwangabo PC, Mvukiyumwani J, Screening of hundred 
Rwandese medicinal plants for antimicrobial and antiviral 
properties. Journal of Ethnopharmacology, 1995; 46: 31‐47. 
34. Jaiprakash B, Chandramohan D, Reddy N, Burn wound healing 
activity of Euphorbia hirta, Ancient Science of Life, 2006; 
25(3&4): 1‐3. 
35. Liu Y, Murakami N, Ji H, Abreu Pedro and Zhang S, 
Antimalarial flavonol glycosides from Euphorbia hirta, 
Pharmaceutical Biology,  2007; 45: 278‐81. 
 
 
